NCT05040815View on ClinicalTrials.gov

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 11, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Anal Canal Cancer
Interventions
RADIATION

chemo-radiation treatment

Radiotherapy (RT) with concurrent 5-fluorouracil and mitomycin-C (5FU/MMC) combination is the treatment of choice for non-metastatic locally advanced anal squam

Trial Locations (1)

T6G 1Z2

RECRUITING

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER